Optimized Curcumin with Neurophenol 60 Vcaps

  • Sale Price: $45.00
  • Availability: Usually ships in 24 hours

$45.00

Product Detail

Product Description

Optimized Curcumin with Neurophenol 60 Vegetarian Capsules. Optimized Curcumin with Neurophenol is a unique formula containing 2 clinically supported and trademarked ingredients: Longvida Optimized Curcumin with extended absorption and bioavailability and Neurophenol proprietary blend of standardized blueberry and grape extracts. Both ingredients support cognitive function in healthy aging adults.Functions:Longvida Optimized Curcumin based on patent pending discoveries from UCLA is a revolutionary new ingredient for healthy brain aging. Longvidas Solid Lipid Curcumin Particle (SLCP) Technology meets all three requirements for bioavailability: solubility permeability and stability as evidenced by therapeutic levels of free curcumin detected in the bloodstream and target tissues. The SLCP technology formulation precisely preserves curcumin particles in a solid lipid base in a way that preserves and protects the curcumin from the harsh environment of the stomach and allows it to dissolve at the optimal point for absorption in the GI tract. The end result permits maximal absorption of the active free form of curcumin. Curcumin is insoluble in water at neutral and acidic pH undergoes rapid glucuronidation and is generally thought to be poorly bioavailable and rapidly excreted. Several human pharmacokinetic studies have only detected curcumin in blood in the inactive glucuronide form. Free curcumin is the only form that has been shown to pass the blood brain barrier.Longvida Curcumin is supported by more than a dozen bioavailability studies showing extended absorption and 65 times more bioavailability than typical curcuminoids with a half-life of 7 hours versus 2 hours for phospholipid curcumin and 0-1 hours for unformulated curcumin.Longvida Curcumin has placebo controlled clinical research to support its role more than 10 cognitive pathways. A 30 day randomized placebo controlled trial with low dose Longvida (400mg) in healthy middle aged subjects led to significant sup